Cargando…

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review

Background and objective: Changes in cannabis legalization regimes in several countries have influenced the diversification of cannabis use. There is an ever-increasing number of cannabis forms available, which are gaining popularity for both recreational and therapeutic use. From a therapeutic pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poyatos, Lourdes, Pérez-Acevedo, Ana Pilar, Papaseit, Esther, Pérez-Mañá, Clara, Martin, Soraya, Hladun, Olga, Siles, Adrià, Torrens, Marta, Busardo, Francesco Paolo, Farré, Magí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353904/ https://www.ncbi.nlm.nih.gov/pubmed/32585912 http://dx.doi.org/10.3390/medicina56060309

Ejemplares similares

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
por: Busardò, Francesco Paolo, et al.
Publicado: (2021)

Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
por: Hladun, Olga, et al.
Publicado: (2021)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
por: Pérez-Acevedo, Ana Pilar, et al.
Publicado: (2020)

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users
por: Maida, Nunzia La, et al.
Publicado: (2021)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

Abuse Potential of Cathinones in Humans: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Pharmacological effects of methylone and MDMA in humans
por: Poyatos, Lourdes, et al.
Publicado: (2023)

Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018)

Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS
por: La Maida, Nunzia, et al.
Publicado: (2020)

Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study
por: Martínez, Lucia, et al.
Publicado: (2021)

Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
por: Sprega, Giorgia, et al.
Publicado: (2023)

Acute human exposure assessment to tetrahydrocannabinol (Δ(9)‐THC)
por: Arcella, Davide, et al.
Publicado: (2020)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

GC–MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study
por: Nuñez-Montero, Melani, et al.
Publicado: (2023)

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
por: Wurz, Gregory T., et al.
Publicado: (2022)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
por: Di Giorgi, Alessandro, et al.
Publicado: (2023)

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
por: Mas, Marta, et al.
Publicado: (2022)

Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function
por: Bossong, Matthijs G., et al.
Publicado: (2013)

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2018)

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice
por: Parks, Cory, et al.
Publicado: (2021)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers
por: Martínez-Riera, Roser, et al.
Publicado: (2019)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans
por: Papaseit, Esther, et al.
Publicado: (2021)

Δ(9)-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial
por: Adam, Kirsten C. S., et al.
Publicado: (2020)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
por: Boonyayothin, Wanuttha, et al.
Publicado: (2022)

Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model
por: Stauch, Chris M., et al.
Publicado: (2020)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2022)

Evaluating the effect of Tetrahydrocannabinol (∆9-THC) extracted from Cannabis sativa plant on spatial memory consolidation in rats
por: Ebrhimpour, Saeedeh, et al.
Publicado: (2010)

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)

Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles
por: Williams, Julie C., et al.
Publicado: (2015)

Cannabis sativa (Hemp) Seeds, Δ(9)-Tetrahydrocannabinol, and Potential Overdose
por: Yang, Yi, et al.
Publicado: (2017)

A Critical Review of the Role of the Cannabinoid Compounds Δ(9)-Tetrahydrocannabinol (Δ(9)-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
por: Jones, Éamon, et al.
Publicado: (2020)

Chronic low-dose Δ(9)-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice
por: Komorowska-Müller, Joanna Agnieszka, et al.
Publicado: (2023)

Sex differences in acute delta-9-tetrahydrocannabinol (Δ(9)-THC) response and tolerance as a function of mouse strain
por: Lulek, Courtney F., et al.
Publicado: (2023)

Identification of candidate genes affecting Δ(9)-tetrahydrocannabinol biosynthesis in Cannabis sativa
por: Marks, M. David, et al.
Publicado: (2009)

Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
por: Ramaekers, Johannes G., et al.
Publicado: (2022)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ejkbpg960l1omklvjs37rrmuuh